Example: Heart Attack
Clinical Trials on Glabellar Crease
Total 10000 results
-
NCT04872166RecruitingMetastatic Breast Cancer | Advanced Solid Tumor
-
NCT04576143RecruitingHER2-negative Breast Cancer | Neoadjuvant Chemotherapy
-
NCT04174352RecruitingERα+ Breast Cancer | ESR1 Gene Mutation
-
NCT04993430Active, not recruitingER-Positive, HER2-Negative Breast Cancer
-
NCT06975371CompletedAdvanced/Metastatic HER2-negative Breast Cancer
-
NCT06243796Completed
-
NCT06957379Active, not recruitingHR+/HER2- Advanced/Metastatic Breast Cancer
-
NCT03709134CompletedBreast Cancer | Breast Neoplasms | Cancer, Breast
-
NCT03950570CompletedMetastatic Breast Cancer | Advanced Solid Tumor
-
NCT01867879CompletedAdvanced Solid Tumors (Excluding Breast Cancer)
-
-
NCT05364255CompletedER-positive, HER2-negative Breast Cancer
-
NCT03719495CompletedHealthy | Breast Cancer | Estrogen Receptor-positive Breast Cancer
-
NCT04588935Completed
-
NCT02384239CompletedMetastatic Breast Cancer | Hormone Receptor Positive
-
NCT02447328CompletedMetastatic Breast Cancer | Locally Advanced or
-
NCT03706573No longer availableHR+ Advanced or Metastatic Breast Cancer
-
NCT03771183CompletedBreast Cancer Patients | Therapy Related Tumor
-
NCT01983501CompletedHER2 Positive Breast Cancers
-
NCT01827163CompletedHER2-Positive Early Stage Breast Cancer
-
-
NCT03768479UnknownEstrogen Receptor-positive Breast Cancer | Fulvestrant
-
NCT03637738Active, not recruitingMenopausal Patients | Low-risk Breast Cancer
-
NCT01769625CompletedBiomarker Change Linked to Breast Cancer
-
NCT02310984Completed
-
NCT00237198CompletedPostmenopausal Women With Advanced Breast Cancer
-
NCT00454805CompletedAdvanced Breast Cancer
-
NCT01325428Completed
-
NCT01344967CompletedMetastatic Breast Cancer With Bone Involvement
-
-
NCT00106145CompletedAdvanced Breast Cancer | Other Solid Tumors
-
NCT00146042CompletedHER-2 Positive Metastatic Breast Cancer
-
NCT00247663CompletedPostmenopausal Women With Advanced Breast Cancer
-
NCT01216124AvailableTriple Negative Local Advanced Breast Cancer
-
NCT00637325UnknownMetastatic or Locally Advanced Breast Cancer
-
NCT06153836RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8
-
NCT04750473CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Invasive Breast Lobular Carcinoma | Metastatic Breast Lobular Carcinoma
-
NCT04756505WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | Hormone Receptor Positive Breast Adenocarcinoma | Metastatic HER2 Negative Breast Adenocarcinoma
-
NCT02892734TerminatedStage IV Breast Cancer | HER2/Neu Negative | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast Carcinoma
-
NCT05216432RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA Mutation
-
NCT04180579Active, not recruitingBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III
-
NCT06238986TerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8
-
NCT05041101TerminatedBreast Inflammatory Carcinoma | Recurrent Breast Inflammatory Carcinoma | Stage IV Breast Inflammatory Carcinoma
-
NCT02620280CompletedInvasive Ductal Breast Carcinoma
-
NCT07102940Not yet recruitingBreast Cancer | HER 2 Negative Breast Cancer | HR Positive/HER-2 Negative Breast Cancer | Stage 1-3
-
NCT07553702Active, not recruitingBreast Cancer | Breast - Female | Breast Cancer Females
-
NCT03137693TerminatedBreast Cancer | Breast Cancer Female | Breast Adenocarcinoma
-
NCT05109988CompletedParents | Breast Feeding, Exclusive
-
NCT00690339CompletedBreast Augmentation | Breast Reconstruction | Revision of Augmentation or Reconstruction